Institutional shares held 51.7 Million
7K calls
6.1K puts
Total value of holdings $344M
$46K calls
$40K puts
Market Cap $101M
15,178,000 Shares Out.
Institutional ownership 340.82%
# of Institutions 118


Latest Institutional Activity in ATXS

Top Purchases

Q2 2025
Affinity Asset Advisors, LLC Shares Held: 300K ($2M)
Q2 2025
Adage Capital Partners Gp, L.L.C. Shares Held: 875K ($5.82M)
Q2 2025
Fcpm Iii Services B.V. Shares Held: 4.11M ($27.3M)
Q2 2025
Nuveen, LLC Shares Held: 369K ($2.46M)
Q2 2025
Logos Global Management LP Shares Held: 700K ($4.66M)

Top Sells

Q2 2025
Ubs Group Ag Shares Held: 712K ($4.74M)
Q2 2025
Vanguard Group Inc Shares Held: 2.52M ($16.8M)
Q2 2025
Northern Trust Corp Shares Held: 376K ($2.5M)
Q2 2025
Gsa Capital Partners LLP Shares Held: 30.9K ($206K)
Q2 2025
State Street Corp Shares Held: 934K ($6.21M)

About ATXS

Astria Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare and niche allergic, and immunological diseases in the United States. Its lead product candidate is STAR-0215, a monoclonal antibody inhibitor of plasma kallikrein, which is in preclinical development stage for the treatment of hereditary angioedema. The company was formerly known as Catabasis Pharmaceuticals, Inc. and changed its name to Astria Therapeutics, Inc. in September 2021. Astria Therapeutics, Inc. was incorporated in 2008 and is based in Boston, Massachusetts.


Insider Transactions at ATXS

Insider Transaction List

View all
Date Insider Transaction Ownership Type Shares Traded Value / Price
View All Transactions

Last 12 Months Summary

Buy / Acquisition
0 Shares
From 0 Insiders
Sell / Disposition
0 Shares
From 0 Insiders

Track Institutional and Insider Activities on ATXS

Follow Astria Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ATXS shares.

Notify only if

Insider Trading

Get notified when an Astria Therapeutics, Inc. insider buys or sells ATXS shares.

Notify only if

News

Receive news related to Astria Therapeutics, Inc.

Track Activities on ATXS